(Q73775013)

English

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

scientific article published on 01 August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

author name string

Braun J

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Brandt J

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Listing J

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Zink A

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Alten R

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Burmester G

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Golder W

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gromnica-Ihle E

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kellner H

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schneider M

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sörensen H

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Zeidler H

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Reddig J

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sieper J

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Arthritis and Rheumatism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2224-2233

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Is methotrexate effective in ankylosing spondylitis?

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Infliximab treatment of severe ankylosing spondylitis: one-year followup

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Radiologic diagnosis and pathology of the spondyloarthropathies.

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Immune linkages between inflammatory bowel disease and spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1002%2FART.11104

21 January 2018

Identifiers

10.1002/ART.11104

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12905476%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73775013&oldid=1759857936"